Bioretec Ltd.

As of June 30, 2026, Bioretec Ltd. carries a market capitalization of 29.79M, placing it among publicly traded companies globally. Its enterprise value stands at 17.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bioretec Ltd.'s next confirmed earnings release is scheduled for February 12, 2027.

As of June 30, 2026, Bioretec Ltd. has 1.34B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Bioretec Ltd. maintains a current ratio of 7.18, meaning it holds 7.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Bioretec Ltd.'s stock has declined approximately 83.25% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.03.

These figures are as of June 30, 2026. Total book value stands at 17.96M, with working capital of 15.53M providing operational flexibility.

Bioretec Ltd.'s most recent stock split took place on March 30, 2026 with a 442:4809 split ratio.